Literature DB >> 6812685

A regimen for low-dose aspirin?

S P Hanley, J Bevan, S R Cockbill, S Heptinstall.   

Abstract

The effects of different regimens of 40 mg aspirin on platelet thromboxane A2 synthesis and vascular prostacyclin synthesis were determined in patients who were undergoing elective surgery for removal of varicose veins. Aspirin 40 mg taken at intervals of 48 hours consistently reduced platelet thromboxane A2 synthesis to a level at which it failed to support platelet aggregation and the associated release reaction. This effect lasted for at least 36 hours. In contrast, aspirin 40 mg every 72 hours did not have the same consistent effect. Both dose regimens led to a reduction in vascular prostacyclin synthesis 12 hours after the last dose, but 36 or 72 hours after the last dose prostacyclin synthesis was not reduced; thus the inhibition of prostacyclin synthesis was short lived. If the balance between platelet thromboxane A2 and vascular prostacyclin synthesis is important in thrombosis 40 mg aspirin every 48 hours may have the maximum antithrombotic effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812685     DOI: 10.1136/bmj.285.6351.1299

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts.

Authors:  N L Baenziger; P R Becherer; P W Majerus
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely dissociated.

Authors:  S Villa; M Livio; G de Gaetano
Journal:  Br J Haematol       Date:  1979-07       Impact factor: 6.998

3.  Prostacyclin and thromboxane generating systems in rabbits pretreated with aspirin.

Authors:  M Basista; J Dobranowski; R J Gryglewski
Journal:  Pharmacol Res Commun       Date:  1978-09

4.  Aspirin and platelets.

Authors:  E M Hoogendijk; J W ten Cate
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

5.  An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

Authors:  S Moncada; R Gryglewski; S Bunting; J R Vane
Journal:  Nature       Date:  1976-10-21       Impact factor: 49.962

6.  Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin.

Authors:  E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

7.  Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.

Authors:  E F Ellis; K F Wright; P S Jones; D W Richardson; C K Ellis
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

8.  Inhibition of platelet prostaglandin synthetase by oral aspirin.

Authors:  J W Burch; N Stanford; P W Majerus
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Effects of intravenous infusion of prostacyclin (PGI2) in man.

Authors:  J O'Grady; S Warrington; M J Moti; S Bunting; R Flower; A S Fowle; E A Higgs; S Moncada
Journal:  Prostaglandins       Date:  1980-02

10.  The differential inhibition of prostaglandin synthesis in platelets and vascular tissue in response to aspirin.

Authors:  B S Shaikh; S J Bott; L M Demers
Journal:  Prostaglandins Med       Date:  1980-06
View more
  6 in total

1.  Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

Authors:  W N Charman; S A Charman; D C Monkhouse; S E Frisbee; E A Lockhart; S Weisman; G A Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 2.  Low-dose aspirin in prevention of toxaemia of pregnancy. Does it have a place?

Authors:  W F Lubbe
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

3.  Lung function and plasma levels of thromboxane B2, 6-ketoprostaglandin F1 alpha and beta-thromboglobulin in antigen-induced asthma before and after indomethacin pretreatment.

Authors:  E G Shephard; L Malan; C M Macfarlane; W Mouton; J R Joubert
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

4.  The effects of the combined administration of beta-adrenoceptor antagonists and non-steroidal anti-inflammatory drugs on ligation-induced arrhythmias in rats.

Authors:  O Fagbemi
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

Review 5.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

6.  Cardiovascular abnormalities in Kawasaki disease.

Authors:  V M Novelli; A Galbraith; P J Robinson; J F Smallhorn; W C Marshall
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.